PURE Bioscience, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $1.3M | $1.6M |
| FY2018 | — | $1.3M | $851.0K |
| FY2019 | — | $1.2M | $398.0K |
| FY2020 | — | $4.8M | $3.8M |
| FY2021 | — | $3.3M | $2.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $1.3M | $1.6M |
| FY2018 | — | $1.3M | $851.0K |
| FY2019 | — | $1.2M | $398.0K |
| FY2020 | — | $4.8M | $3.8M |
| FY2021 | — | $3.3M | $2.4M |